- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06018038
Arm Exercise Capacity and Maximal Oxygen Consumption With Breast Cancer
A Comparison of Upper Extremity Exercise Capacity, Maximum Oxygen Consumption, Daily Activities, and Physical Activity Level in Breast Cancer and Healthy Individuals
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In recent years, thanks to the increasing treatment possibilities with the developing technology, the majority of patients show good functional recovery after breast cancer. However, it has been reported that the treatments negatively affect the functional capacity of the upper extremities, daily life, work and social activities and reduce the quality of life. It has also been reported that breast cancer-related lymphedema (BCRL) may both cause and exacerbate treatment-related complications such as decreased functional capacity of the upper extremities and worsened quality of life after breast cancer treatments. In addition, it has been found that lymphedema decreases the muscle strength and range of motion of the limb in which it develops and causes an increase in symptoms such as pain, fatigue and discomfort. These complications caused by lymphedema lead to decreased functional level of the upper extremity, activity limitations and decreased quality of life. Cardiovascular health is negatively affected after breast cancer. Decreased cardiorespiratory performance also has direct consequences on daily task performance and therefore quality of life is negatively affected.
The gold standard method of measuring cardiorespiratory exercise capacity is cardiopulmonary exercise testing (CPET). This method determines the causes of limitation during exercise and gives maximal oxygen consumption (VO2max) as a measure of maximum performance. In cancer patients, the oxygen system may be adversely affected by chemotherapy. Effects of chemotherapeutic agents on respiratory, cardiac, blood, vascular or skeletal muscle functions have been observed, potentially contributing to impaired cardiorespiratory fitness. Cardiorespiratory function is not routinely measured at any stage of breast cancer treatment and CPET is rarely used in clinical settings. Although low VO2max measurements have been observed in intervention studies during breast cancer survivorship and these studies were conducted without the use of an arm ergometer, to our knowledge, there is very limited information on the impact of cancer treatment on cardiorespiratory fitness using gold standard testing methods.
Although decreased functional capacity is common after breast cancer treatment, there are few studies evaluating maximal arm exercise capacity with oxygen consumption.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Ebru Calik Kutukcu, PhD
- Phone Number: 195 +903123051576
- Email: ebru.calik@hacettepe.edu.tr
Study Contact Backup
- Name: Naciye Vardar-Yagli, PhD
- Phone Number: 129 +03123051576
- Email: naciyevardar@yahoo.com
Study Locations
-
-
-
Ankara, Turkey
- HACETTEPE UNIVERSİTY
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Breast Cancer Group:
- Being between 18-65 years of age,
- Volunteering to participate in the research,
- Stage I-III breast cancer,
- At least 15 months after breast cancer surgery,
- Six months after active breast cancer treatment (i.e. surgery/chemotherapy),
- No problems in reading and/or understanding the scales and being able to cooperate with the tests,
Healthy group:
- Age between 18-65 years,
- Volunteering to participate in the research,
- No problems in reading and/or understanding the scales and being able to cooperate with the tests.
Exclusion Criteria:
Breast Cancer Group:
- Presence of active infection,
- Musculoskeletal and neurological diseases that may affect exercise performance, symptomatic heart disease,
- Having a neurological disease or other clinical diagnosis that may affect cognitive status.
Healthy group:
- Having any orthopedic or neuromuscular condition that would interfere with walking or exercise performance,
- Having any chronic disease or psychiatric disorders or mental impairments that may interfere with cooperation or compliance with exercise tests
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Breast Cancer Group
Inclusion criteria were to be between 18-65 years of age, to volunteer to participate in the study, to have Stage I-III breast cancer, to have at least 15 months after breast cancer surgery, to have six months after active breast cancer treatment (i.e.
surgery/chemotherapy), to have no problems in reading and/or understanding the scales and to be able to cooperate with the tests.
Exclusion criteria were the presence of active infection, musculoskeletal and neurologic disease that may affect exercise performance, symptomatic heart disease, neurologic disease or other clinical diagnosis that may affect cognitive status.
|
Cardiopulmonary Exercise Testing (CPET)
|
Control Group
The inclusion criteria were to be between 18-65 years of age, to be willing to participate in the study, to have no problems in reading and/or understanding the scales and to be able to cooperate with the tests.
Exclusion criteria were having any orthopedic or neuromuscular condition that would interfere with walking or exercise performance, having any chronic disease, or having psychiatric disorders or mental disorders that might interfere with cooperation or compliance with exercise tests.
|
Cardiopulmonary Exercise Testing (CPET)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiopulmonary Exercise Testing (CPET)
Time Frame: One Year
|
Maximal Oxygen Consumption (VO2max)
|
One Year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Upper Extremity Oxidative Muscle Metabolism
Time Frame: One Year
|
Muscle Oxygen Saturation (SmO2 )
|
One Year
|
Upper Limb Functionality
Time Frame: One Year
|
Upper Limb Functional Test (ULIFT)
|
One Year
|
Evaluation of Quality of Life
Time Frame: One Year
|
European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) All scores were linearly transformed to a 0 to 100 scale.
A high or healthy level of functioning is represented by a high functional score
|
One Year
|
Peripheral Muscle Strength
Time Frame: One Year
|
Hand grip strength by hand dynamometer
|
One Year
|
Physical activity levels
Time Frame: One Year
|
The International Physical Activity Questionnaire - Short Form (IPAQ-SF) The physical activity status of participants was grouped as follows: (a) inactive [≤600 metabolic equivalent MET)-min/week]; (b) minimum active (>600 up to ≤3000 MET-min/week); and (c) active (>3000 MET-min/week)
|
One Year
|
Pain Assessment
Time Frame: One Year
|
McGill Pain Scale McGill pain scale determines the severity of pain and is divided into zero, which means no pain, and 10, which means severe pain;
|
One Year
|
Fatigue Measurement
Time Frame: One Year
|
Piper Fatigue Scale (PFS) Responses for each item It is evaluated between 0-10 points.
The total fatigue score is based on 22 items scores are summed and divided by the number of items.
Scale obtained from high scores indicate a high level of perceived fatigue shows.
|
One Year
|
anthropometric measurements
Time Frame: One Year
|
Arm Circumference
|
One Year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ebru Calik Kutukcu, PhD, HACETTEPE UNIVERSİTY
- Study Chair: Melda Saglam, PhD, HACETTEPE UNIVERSİTY
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GO 23/489
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Maximal Exercise Capacity, Maximal Oxygen Consumption (VO2max)
-
University of ZurichCompletedHigh Altitude Pulmonary Hypertension | Maximal Exercise CapacitySwitzerland
-
Vanderbilt University Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)CompletedPostural Orthostatic Tachycardia SyndromeUnited States
-
AdventHealth Translational Research InstituteActive, not recruiting
-
AdventHealth Translational Research InstituteActive, not recruiting
-
Hacettepe UniversityCompletedSingle-ventricle | Exercise Capacity | Hemodynamic Instability | Arterial Stiffness | Muscle Oxygenation | Fontan ProcedureTurkey
-
Diakonhjemmet HospitalRecruiting
-
Boston Children's HospitalUniversity of Colorado, DenverCompletedConcussion, Mild | Concussion, Brain | Concussion, Severe | Exertion; ExcessUnited States
-
The Baruch Padeh Medical Center, PoriyaRecruiting
-
Universidade Federal de PernambucoUnknownHeart FailureBrazil
-
Fundación para la Investigación del Hospital Clínico...CompletedHeart Failure With Reduced Ejection FractionSpain